Global Recombinant Human Interleukin-2 Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Recombinant Human Interleukin-2 (IL-2) is a therapeutic protein used in medicine, particularly in immunotherapy. Interleukin-2 is a naturally occurring cytokine produced by activated T cells, and it plays a crucial role in regulating the immune response. Recombinant IL-2 is produced through genetic engineering techniques, where the IL-2 gene is inserted into host cells (such as bacteria, yeast, or mammalian cells) to produce large quantities of the protein.
The global Recombinant Human Interleukin-2 market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Recombinant Human Interleukin-2 Industry Forecast” looks at past sales and reviews total world Recombinant Human Interleukin-2 sales in 2023, providing a comprehensive analysis by region and market sector of projected Recombinant Human Interleukin-2 sales for 2024 through 2030. With Recombinant Human Interleukin-2 sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Recombinant Human Interleukin-2 industry.
This Insight Report provides a comprehensive analysis of the global Recombinant Human Interleukin-2 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Recombinant Human Interleukin-2 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Recombinant Human Interleukin-2 market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Recombinant Human Interleukin-2 and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Recombinant Human Interleukin-2.
United States market for Recombinant Human Interleukin-2 is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Recombinant Human Interleukin-2 is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Recombinant Human Interleukin-2 is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Recombinant Human Interleukin-2 players cover Cytiva, Bio-Techne, Lonza, Sartorius CellGenix, Thermo Fisher Scientific, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Human Interleukin-2 market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Recombinant Human Interleukin-2 market?
What factors are driving Recombinant Human Interleukin-2 market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Recombinant Human Interleukin-2 market opportunities vary by end market size?
How does Recombinant Human Interleukin-2 break out by Type, by Application?
Recombinant Human Interleukin-2 (IL-2) is a therapeutic protein used in medicine, particularly in immunotherapy. Interleukin-2 is a naturally occurring cytokine produced by activated T cells, and it plays a crucial role in regulating the immune response. Recombinant IL-2 is produced through genetic engineering techniques, where the IL-2 gene is inserted into host cells (such as bacteria, yeast, or mammalian cells) to produce large quantities of the protein.
The global Recombinant Human Interleukin-2 market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Recombinant Human Interleukin-2 Industry Forecast” looks at past sales and reviews total world Recombinant Human Interleukin-2 sales in 2023, providing a comprehensive analysis by region and market sector of projected Recombinant Human Interleukin-2 sales for 2024 through 2030. With Recombinant Human Interleukin-2 sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Recombinant Human Interleukin-2 industry.
This Insight Report provides a comprehensive analysis of the global Recombinant Human Interleukin-2 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Recombinant Human Interleukin-2 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Recombinant Human Interleukin-2 market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Recombinant Human Interleukin-2 and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Recombinant Human Interleukin-2.
United States market for Recombinant Human Interleukin-2 is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Recombinant Human Interleukin-2 is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Recombinant Human Interleukin-2 is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Recombinant Human Interleukin-2 players cover Cytiva, Bio-Techne, Lonza, Sartorius CellGenix, Thermo Fisher Scientific, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Human Interleukin-2 market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Pharmaceutical Grade
- Other
- Medical
- Culture Medium Supplement
- Scientific Research
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Cytiva
- Bio-Techne
- Lonza
- Sartorius CellGenix
- Thermo Fisher Scientific
- Miltenyi Biotec
- Akron Biotech
- Sino Biological
- Creative Bioarray
What is the 10-year outlook for the global Recombinant Human Interleukin-2 market?
What factors are driving Recombinant Human Interleukin-2 market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Recombinant Human Interleukin-2 market opportunities vary by end market size?
How does Recombinant Human Interleukin-2 break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Recombinant Human Interleukin-2 Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Recombinant Human Interleukin-2 by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Recombinant Human Interleukin-2 by Country/Region, 2019, 2023 & 2030
2.2 Recombinant Human Interleukin-2 Segment by Type
2.2.1 Pharmaceutical Grade
2.2.2 Other
2.3 Recombinant Human Interleukin-2 Sales by Type
2.3.1 Global Recombinant Human Interleukin-2 Sales Market Share by Type (2019-2024)
2.3.2 Global Recombinant Human Interleukin-2 Revenue and Market Share by Type (2019-2024)
2.3.3 Global Recombinant Human Interleukin-2 Sale Price by Type (2019-2024)
2.4 Recombinant Human Interleukin-2 Segment by Application
2.4.1 Medical
2.4.2 Culture Medium Supplement
2.4.3 Scientific Research
2.5 Recombinant Human Interleukin-2 Sales by Application
2.5.1 Global Recombinant Human Interleukin-2 Sale Market Share by Application (2019-2024)
2.5.2 Global Recombinant Human Interleukin-2 Revenue and Market Share by Application (2019-2024)
2.5.3 Global Recombinant Human Interleukin-2 Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Recombinant Human Interleukin-2 Breakdown Data by Company
3.1.1 Global Recombinant Human Interleukin-2 Annual Sales by Company (2019-2024)
3.1.2 Global Recombinant Human Interleukin-2 Sales Market Share by Company (2019-2024)
3.2 Global Recombinant Human Interleukin-2 Annual Revenue by Company (2019-2024)
3.2.1 Global Recombinant Human Interleukin-2 Revenue by Company (2019-2024)
3.2.2 Global Recombinant Human Interleukin-2 Revenue Market Share by Company (2019-2024)
3.3 Global Recombinant Human Interleukin-2 Sale Price by Company
3.4 Key Manufacturers Recombinant Human Interleukin-2 Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Recombinant Human Interleukin-2 Product Location Distribution
3.4.2 Players Recombinant Human Interleukin-2 Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR RECOMBINANT HUMAN INTERLEUKIN-2 BY GEOGRAPHIC REGION
4.1 World Historic Recombinant Human Interleukin-2 Market Size by Geographic Region (2019-2024)
4.1.1 Global Recombinant Human Interleukin-2 Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Recombinant Human Interleukin-2 Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Recombinant Human Interleukin-2 Market Size by Country/Region (2019-2024)
4.2.1 Global Recombinant Human Interleukin-2 Annual Sales by Country/Region (2019-2024)
4.2.2 Global Recombinant Human Interleukin-2 Annual Revenue by Country/Region (2019-2024)
4.3 Americas Recombinant Human Interleukin-2 Sales Growth
4.4 APAC Recombinant Human Interleukin-2 Sales Growth
4.5 Europe Recombinant Human Interleukin-2 Sales Growth
4.6 Middle East & Africa Recombinant Human Interleukin-2 Sales Growth
5 AMERICAS
5.1 Americas Recombinant Human Interleukin-2 Sales by Country
5.1.1 Americas Recombinant Human Interleukin-2 Sales by Country (2019-2024)
5.1.2 Americas Recombinant Human Interleukin-2 Revenue by Country (2019-2024)
5.2 Americas Recombinant Human Interleukin-2 Sales by Type (2019-2024)
5.3 Americas Recombinant Human Interleukin-2 Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Recombinant Human Interleukin-2 Sales by Region
6.1.1 APAC Recombinant Human Interleukin-2 Sales by Region (2019-2024)
6.1.2 APAC Recombinant Human Interleukin-2 Revenue by Region (2019-2024)
6.2 APAC Recombinant Human Interleukin-2 Sales by Type (2019-2024)
6.3 APAC Recombinant Human Interleukin-2 Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Recombinant Human Interleukin-2 by Country
7.1.1 Europe Recombinant Human Interleukin-2 Sales by Country (2019-2024)
7.1.2 Europe Recombinant Human Interleukin-2 Revenue by Country (2019-2024)
7.2 Europe Recombinant Human Interleukin-2 Sales by Type (2019-2024)
7.3 Europe Recombinant Human Interleukin-2 Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Recombinant Human Interleukin-2 by Country
8.1.1 Middle East & Africa Recombinant Human Interleukin-2 Sales by Country (2019-2024)
8.1.2 Middle East & Africa Recombinant Human Interleukin-2 Revenue by Country (2019-2024)
8.2 Middle East & Africa Recombinant Human Interleukin-2 Sales by Type (2019-2024)
8.3 Middle East & Africa Recombinant Human Interleukin-2 Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Recombinant Human Interleukin-2
10.3 Manufacturing Process Analysis of Recombinant Human Interleukin-2
10.4 Industry Chain Structure of Recombinant Human Interleukin-2
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Recombinant Human Interleukin-2 Distributors
11.3 Recombinant Human Interleukin-2 Customer
12 WORLD FORECAST REVIEW FOR RECOMBINANT HUMAN INTERLEUKIN-2 BY GEOGRAPHIC REGION
12.1 Global Recombinant Human Interleukin-2 Market Size Forecast by Region
12.1.1 Global Recombinant Human Interleukin-2 Forecast by Region (2025-2030)
12.1.2 Global Recombinant Human Interleukin-2 Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Recombinant Human Interleukin-2 Forecast by Type (2025-2030)
12.7 Global Recombinant Human Interleukin-2 Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Cytiva
13.1.1 Cytiva Company Information
13.1.2 Cytiva Recombinant Human Interleukin-2 Product Portfolios and Specifications
13.1.3 Cytiva Recombinant Human Interleukin-2 Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Cytiva Main Business Overview
13.1.5 Cytiva Latest Developments
13.2 Bio-Techne
13.2.1 Bio-Techne Company Information
13.2.2 Bio-Techne Recombinant Human Interleukin-2 Product Portfolios and Specifications
13.2.3 Bio-Techne Recombinant Human Interleukin-2 Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Bio-Techne Main Business Overview
13.2.5 Bio-Techne Latest Developments
13.3 Lonza
13.3.1 Lonza Company Information
13.3.2 Lonza Recombinant Human Interleukin-2 Product Portfolios and Specifications
13.3.3 Lonza Recombinant Human Interleukin-2 Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Lonza Main Business Overview
13.3.5 Lonza Latest Developments
13.4 Sartorius CellGenix
13.4.1 Sartorius CellGenix Company Information
13.4.2 Sartorius CellGenix Recombinant Human Interleukin-2 Product Portfolios and Specifications
13.4.3 Sartorius CellGenix Recombinant Human Interleukin-2 Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Sartorius CellGenix Main Business Overview
13.4.5 Sartorius CellGenix Latest Developments
13.5 Thermo Fisher Scientific
13.5.1 Thermo Fisher Scientific Company Information
13.5.2 Thermo Fisher Scientific Recombinant Human Interleukin-2 Product Portfolios and Specifications
13.5.3 Thermo Fisher Scientific Recombinant Human Interleukin-2 Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Thermo Fisher Scientific Main Business Overview
13.5.5 Thermo Fisher Scientific Latest Developments
13.6 Miltenyi Biotec
13.6.1 Miltenyi Biotec Company Information
13.6.2 Miltenyi Biotec Recombinant Human Interleukin-2 Product Portfolios and Specifications
13.6.3 Miltenyi Biotec Recombinant Human Interleukin-2 Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Miltenyi Biotec Main Business Overview
13.6.5 Miltenyi Biotec Latest Developments
13.7 Akron Biotech
13.7.1 Akron Biotech Company Information
13.7.2 Akron Biotech Recombinant Human Interleukin-2 Product Portfolios and Specifications
13.7.3 Akron Biotech Recombinant Human Interleukin-2 Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Akron Biotech Main Business Overview
13.7.5 Akron Biotech Latest Developments
13.8 Sino Biological
13.8.1 Sino Biological Company Information
13.8.2 Sino Biological Recombinant Human Interleukin-2 Product Portfolios and Specifications
13.8.3 Sino Biological Recombinant Human Interleukin-2 Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Sino Biological Main Business Overview
13.8.5 Sino Biological Latest Developments
13.9 Creative Bioarray
13.9.1 Creative Bioarray Company Information
13.9.2 Creative Bioarray Recombinant Human Interleukin-2 Product Portfolios and Specifications
13.9.3 Creative Bioarray Recombinant Human Interleukin-2 Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Creative Bioarray Main Business Overview
13.9.5 Creative Bioarray Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Recombinant Human Interleukin-2 Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Recombinant Human Interleukin-2 by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Recombinant Human Interleukin-2 by Country/Region, 2019, 2023 & 2030
2.2 Recombinant Human Interleukin-2 Segment by Type
2.2.1 Pharmaceutical Grade
2.2.2 Other
2.3 Recombinant Human Interleukin-2 Sales by Type
2.3.1 Global Recombinant Human Interleukin-2 Sales Market Share by Type (2019-2024)
2.3.2 Global Recombinant Human Interleukin-2 Revenue and Market Share by Type (2019-2024)
2.3.3 Global Recombinant Human Interleukin-2 Sale Price by Type (2019-2024)
2.4 Recombinant Human Interleukin-2 Segment by Application
2.4.1 Medical
2.4.2 Culture Medium Supplement
2.4.3 Scientific Research
2.5 Recombinant Human Interleukin-2 Sales by Application
2.5.1 Global Recombinant Human Interleukin-2 Sale Market Share by Application (2019-2024)
2.5.2 Global Recombinant Human Interleukin-2 Revenue and Market Share by Application (2019-2024)
2.5.3 Global Recombinant Human Interleukin-2 Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Recombinant Human Interleukin-2 Breakdown Data by Company
3.1.1 Global Recombinant Human Interleukin-2 Annual Sales by Company (2019-2024)
3.1.2 Global Recombinant Human Interleukin-2 Sales Market Share by Company (2019-2024)
3.2 Global Recombinant Human Interleukin-2 Annual Revenue by Company (2019-2024)
3.2.1 Global Recombinant Human Interleukin-2 Revenue by Company (2019-2024)
3.2.2 Global Recombinant Human Interleukin-2 Revenue Market Share by Company (2019-2024)
3.3 Global Recombinant Human Interleukin-2 Sale Price by Company
3.4 Key Manufacturers Recombinant Human Interleukin-2 Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Recombinant Human Interleukin-2 Product Location Distribution
3.4.2 Players Recombinant Human Interleukin-2 Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR RECOMBINANT HUMAN INTERLEUKIN-2 BY GEOGRAPHIC REGION
4.1 World Historic Recombinant Human Interleukin-2 Market Size by Geographic Region (2019-2024)
4.1.1 Global Recombinant Human Interleukin-2 Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Recombinant Human Interleukin-2 Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Recombinant Human Interleukin-2 Market Size by Country/Region (2019-2024)
4.2.1 Global Recombinant Human Interleukin-2 Annual Sales by Country/Region (2019-2024)
4.2.2 Global Recombinant Human Interleukin-2 Annual Revenue by Country/Region (2019-2024)
4.3 Americas Recombinant Human Interleukin-2 Sales Growth
4.4 APAC Recombinant Human Interleukin-2 Sales Growth
4.5 Europe Recombinant Human Interleukin-2 Sales Growth
4.6 Middle East & Africa Recombinant Human Interleukin-2 Sales Growth
5 AMERICAS
5.1 Americas Recombinant Human Interleukin-2 Sales by Country
5.1.1 Americas Recombinant Human Interleukin-2 Sales by Country (2019-2024)
5.1.2 Americas Recombinant Human Interleukin-2 Revenue by Country (2019-2024)
5.2 Americas Recombinant Human Interleukin-2 Sales by Type (2019-2024)
5.3 Americas Recombinant Human Interleukin-2 Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Recombinant Human Interleukin-2 Sales by Region
6.1.1 APAC Recombinant Human Interleukin-2 Sales by Region (2019-2024)
6.1.2 APAC Recombinant Human Interleukin-2 Revenue by Region (2019-2024)
6.2 APAC Recombinant Human Interleukin-2 Sales by Type (2019-2024)
6.3 APAC Recombinant Human Interleukin-2 Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Recombinant Human Interleukin-2 by Country
7.1.1 Europe Recombinant Human Interleukin-2 Sales by Country (2019-2024)
7.1.2 Europe Recombinant Human Interleukin-2 Revenue by Country (2019-2024)
7.2 Europe Recombinant Human Interleukin-2 Sales by Type (2019-2024)
7.3 Europe Recombinant Human Interleukin-2 Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Recombinant Human Interleukin-2 by Country
8.1.1 Middle East & Africa Recombinant Human Interleukin-2 Sales by Country (2019-2024)
8.1.2 Middle East & Africa Recombinant Human Interleukin-2 Revenue by Country (2019-2024)
8.2 Middle East & Africa Recombinant Human Interleukin-2 Sales by Type (2019-2024)
8.3 Middle East & Africa Recombinant Human Interleukin-2 Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Recombinant Human Interleukin-2
10.3 Manufacturing Process Analysis of Recombinant Human Interleukin-2
10.4 Industry Chain Structure of Recombinant Human Interleukin-2
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Recombinant Human Interleukin-2 Distributors
11.3 Recombinant Human Interleukin-2 Customer
12 WORLD FORECAST REVIEW FOR RECOMBINANT HUMAN INTERLEUKIN-2 BY GEOGRAPHIC REGION
12.1 Global Recombinant Human Interleukin-2 Market Size Forecast by Region
12.1.1 Global Recombinant Human Interleukin-2 Forecast by Region (2025-2030)
12.1.2 Global Recombinant Human Interleukin-2 Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Recombinant Human Interleukin-2 Forecast by Type (2025-2030)
12.7 Global Recombinant Human Interleukin-2 Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Cytiva
13.1.1 Cytiva Company Information
13.1.2 Cytiva Recombinant Human Interleukin-2 Product Portfolios and Specifications
13.1.3 Cytiva Recombinant Human Interleukin-2 Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Cytiva Main Business Overview
13.1.5 Cytiva Latest Developments
13.2 Bio-Techne
13.2.1 Bio-Techne Company Information
13.2.2 Bio-Techne Recombinant Human Interleukin-2 Product Portfolios and Specifications
13.2.3 Bio-Techne Recombinant Human Interleukin-2 Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Bio-Techne Main Business Overview
13.2.5 Bio-Techne Latest Developments
13.3 Lonza
13.3.1 Lonza Company Information
13.3.2 Lonza Recombinant Human Interleukin-2 Product Portfolios and Specifications
13.3.3 Lonza Recombinant Human Interleukin-2 Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Lonza Main Business Overview
13.3.5 Lonza Latest Developments
13.4 Sartorius CellGenix
13.4.1 Sartorius CellGenix Company Information
13.4.2 Sartorius CellGenix Recombinant Human Interleukin-2 Product Portfolios and Specifications
13.4.3 Sartorius CellGenix Recombinant Human Interleukin-2 Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Sartorius CellGenix Main Business Overview
13.4.5 Sartorius CellGenix Latest Developments
13.5 Thermo Fisher Scientific
13.5.1 Thermo Fisher Scientific Company Information
13.5.2 Thermo Fisher Scientific Recombinant Human Interleukin-2 Product Portfolios and Specifications
13.5.3 Thermo Fisher Scientific Recombinant Human Interleukin-2 Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Thermo Fisher Scientific Main Business Overview
13.5.5 Thermo Fisher Scientific Latest Developments
13.6 Miltenyi Biotec
13.6.1 Miltenyi Biotec Company Information
13.6.2 Miltenyi Biotec Recombinant Human Interleukin-2 Product Portfolios and Specifications
13.6.3 Miltenyi Biotec Recombinant Human Interleukin-2 Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Miltenyi Biotec Main Business Overview
13.6.5 Miltenyi Biotec Latest Developments
13.7 Akron Biotech
13.7.1 Akron Biotech Company Information
13.7.2 Akron Biotech Recombinant Human Interleukin-2 Product Portfolios and Specifications
13.7.3 Akron Biotech Recombinant Human Interleukin-2 Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Akron Biotech Main Business Overview
13.7.5 Akron Biotech Latest Developments
13.8 Sino Biological
13.8.1 Sino Biological Company Information
13.8.2 Sino Biological Recombinant Human Interleukin-2 Product Portfolios and Specifications
13.8.3 Sino Biological Recombinant Human Interleukin-2 Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Sino Biological Main Business Overview
13.8.5 Sino Biological Latest Developments
13.9 Creative Bioarray
13.9.1 Creative Bioarray Company Information
13.9.2 Creative Bioarray Recombinant Human Interleukin-2 Product Portfolios and Specifications
13.9.3 Creative Bioarray Recombinant Human Interleukin-2 Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Creative Bioarray Main Business Overview
13.9.5 Creative Bioarray Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Recombinant Human Interleukin-2 Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Recombinant Human Interleukin-2 Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Pharmaceutical Grade
Table 4. Major Players of Other
Table 5. Global Recombinant Human Interleukin-2 Sales by Type (2019-2024) & (kg)
Table 6. Global Recombinant Human Interleukin-2 Sales Market Share by Type (2019-2024)
Table 7. Global Recombinant Human Interleukin-2 Revenue by Type (2019-2024) & ($ million)
Table 8. Global Recombinant Human Interleukin-2 Revenue Market Share by Type (2019-2024)
Table 9. Global Recombinant Human Interleukin-2 Sale Price by Type (2019-2024) & (US$/g)
Table 10. Global Recombinant Human Interleukin-2 Sale by Application (2019-2024) & (kg)
Table 11. Global Recombinant Human Interleukin-2 Sale Market Share by Application (2019-2024)
Table 12. Global Recombinant Human Interleukin-2 Revenue by Application (2019-2024) & ($ million)
Table 13. Global Recombinant Human Interleukin-2 Revenue Market Share by Application (2019-2024)
Table 14. Global Recombinant Human Interleukin-2 Sale Price by Application (2019-2024) & (US$/g)
Table 15. Global Recombinant Human Interleukin-2 Sales by Company (2019-2024) & (kg)
Table 16. Global Recombinant Human Interleukin-2 Sales Market Share by Company (2019-2024)
Table 17. Global Recombinant Human Interleukin-2 Revenue by Company (2019-2024) & ($ millions)
Table 18. Global Recombinant Human Interleukin-2 Revenue Market Share by Company (2019-2024)
Table 19. Global Recombinant Human Interleukin-2 Sale Price by Company (2019-2024) & (US$/g)
Table 20. Key Manufacturers Recombinant Human Interleukin-2 Producing Area Distribution and Sales Area
Table 21. Players Recombinant Human Interleukin-2 Products Offered
Table 22. Recombinant Human Interleukin-2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Recombinant Human Interleukin-2 Sales by Geographic Region (2019-2024) & (kg)
Table 26. Global Recombinant Human Interleukin-2 Sales Market Share Geographic Region (2019-2024)
Table 27. Global Recombinant Human Interleukin-2 Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Recombinant Human Interleukin-2 Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Recombinant Human Interleukin-2 Sales by Country/Region (2019-2024) & (kg)
Table 30. Global Recombinant Human Interleukin-2 Sales Market Share by Country/Region (2019-2024)
Table 31. Global Recombinant Human Interleukin-2 Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Recombinant Human Interleukin-2 Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Recombinant Human Interleukin-2 Sales by Country (2019-2024) & (kg)
Table 34. Americas Recombinant Human Interleukin-2 Sales Market Share by Country (2019-2024)
Table 35. Americas Recombinant Human Interleukin-2 Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas Recombinant Human Interleukin-2 Sales by Type (2019-2024) & (kg)
Table 37. Americas Recombinant Human Interleukin-2 Sales by Application (2019-2024) & (kg)
Table 38. APAC Recombinant Human Interleukin-2 Sales by Region (2019-2024) & (kg)
Table 39. APAC Recombinant Human Interleukin-2 Sales Market Share by Region (2019-2024)
Table 40. APAC Recombinant Human Interleukin-2 Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC Recombinant Human Interleukin-2 Sales by Type (2019-2024) & (kg)
Table 42. APAC Recombinant Human Interleukin-2 Sales by Application (2019-2024) & (kg)
Table 43. Europe Recombinant Human Interleukin-2 Sales by Country (2019-2024) & (kg)
Table 44. Europe Recombinant Human Interleukin-2 Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe Recombinant Human Interleukin-2 Sales by Type (2019-2024) & (kg)
Table 46. Europe Recombinant Human Interleukin-2 Sales by Application (2019-2024) & (kg)
Table 47. Middle East & Africa Recombinant Human Interleukin-2 Sales by Country (2019-2024) & (kg)
Table 48. Middle East & Africa Recombinant Human Interleukin-2 Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa Recombinant Human Interleukin-2 Sales by Type (2019-2024) & (kg)
Table 50. Middle East & Africa Recombinant Human Interleukin-2 Sales by Application (2019-2024) & (kg)
Table 51. Key Market Drivers & Growth Opportunities of Recombinant Human Interleukin-2
Table 52. Key Market Challenges & Risks of Recombinant Human Interleukin-2
Table 53. Key Industry Trends of Recombinant Human Interleukin-2
Table 54. Recombinant Human Interleukin-2 Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Recombinant Human Interleukin-2 Distributors List
Table 57. Recombinant Human Interleukin-2 Customer List
Table 58. Global Recombinant Human Interleukin-2 Sales Forecast by Region (2025-2030) & (kg)
Table 59. Global Recombinant Human Interleukin-2 Revenue Forecast by Region (2025-2030) & ($ millions)
Table 60. Americas Recombinant Human Interleukin-2 Sales Forecast by Country (2025-2030) & (kg)
Table 61. Americas Recombinant Human Interleukin-2 Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 62. APAC Recombinant Human Interleukin-2 Sales Forecast by Region (2025-2030) & (kg)
Table 63. APAC Recombinant Human Interleukin-2 Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 64. Europe Recombinant Human Interleukin-2 Sales Forecast by Country (2025-2030) & (kg)
Table 65. Europe Recombinant Human Interleukin-2 Revenue Forecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa Recombinant Human Interleukin-2 Sales Forecast by Country (2025-2030) & (kg)
Table 67. Middle East & Africa Recombinant Human Interleukin-2 Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. Global Recombinant Human Interleukin-2 Sales Forecast by Type (2025-2030) & (kg)
Table 69. Global Recombinant Human Interleukin-2 Revenue Forecast by Type (2025-2030) & ($ millions)
Table 70. Global Recombinant Human Interleukin-2 Sales Forecast by Application (2025-2030) & (kg)
Table 71. Global Recombinant Human Interleukin-2 Revenue Forecast by Application (2025-2030) & ($ millions)
Table 72. Cytiva Basic Information, Recombinant Human Interleukin-2 Manufacturing Base, Sales Area and Its Competitors
Table 73. Cytiva Recombinant Human Interleukin-2 Product Portfolios and Specifications
Table 74. Cytiva Recombinant Human Interleukin-2 Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2019-2024)
Table 75. Cytiva Main Business
Table 76. Cytiva Latest Developments
Table 77. Bio-Techne Basic Information, Recombinant Human Interleukin-2 Manufacturing Base, Sales Area and Its Competitors
Table 78. Bio-Techne Recombinant Human Interleukin-2 Product Portfolios and Specifications
Table 79. Bio-Techne Recombinant Human Interleukin-2 Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2019-2024)
Table 80. Bio-Techne Main Business
Table 81. Bio-Techne Latest Developments
Table 82. Lonza Basic Information, Recombinant Human Interleukin-2 Manufacturing Base, Sales Area and Its Competitors
Table 83. Lonza Recombinant Human Interleukin-2 Product Portfolios and Specifications
Table 84. Lonza Recombinant Human Interleukin-2 Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2019-2024)
Table 85. Lonza Main Business
Table 86. Lonza Latest Developments
Table 87. Sartorius CellGenix Basic Information, Recombinant Human Interleukin-2 Manufacturing Base, Sales Area and Its Competitors
Table 88. Sartorius CellGenix Recombinant Human Interleukin-2 Product Portfolios and Specifications
Table 89. Sartorius CellGenix Recombinant Human Interleukin-2 Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2019-2024)
Table 90. Sartorius CellGenix Main Business
Table 91. Sartorius CellGenix Latest Developments
Table 92. Thermo Fisher Scientific Basic Information, Recombinant Human Interleukin-2 Manufacturing Base, Sales Area and Its Competitors
Table 93. Thermo Fisher Scientific Recombinant Human Interleukin-2 Product Portfolios and Specifications
Table 94. Thermo Fisher Scientific Recombinant Human Interleukin-2 Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2019-2024)
Table 95. Thermo Fisher Scientific Main Business
Table 96. Thermo Fisher Scientific Latest Developments
Table 97. Miltenyi Biotec Basic Information, Recombinant Human Interleukin-2 Manufacturing Base, Sales Area and Its Competitors
Table 98. Miltenyi Biotec Recombinant Human Interleukin-2 Product Portfolios and Specifications
Table 99. Miltenyi Biotec Recombinant Human Interleukin-2 Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2019-2024)
Table 100. Miltenyi Biotec Main Business
Table 101. Miltenyi Biotec Latest Developments
Table 102. Akron Biotech Basic Information, Recombinant Human Interleukin-2 Manufacturing Base, Sales Area and Its Competitors
Table 103. Akron Biotech Recombinant Human Interleukin-2 Product Portfolios and Specifications
Table 104. Akron Biotech Recombinant Human Interleukin-2 Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2019-2024)
Table 105. Akron Biotech Main Business
Table 106. Akron Biotech Latest Developments
Table 107. Sino Biological Basic Information, Recombinant Human Interleukin-2 Manufacturing Base, Sales Area and Its Competitors
Table 108. Sino Biological Recombinant Human Interleukin-2 Product Portfolios and Specifications
Table 109. Sino Biological Recombinant Human Interleukin-2 Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2019-2024)
Table 110. Sino Biological Main Business
Table 111. Sino Biological Latest Developments
Table 112. Creative Bioarray Basic Information, Recombinant Human Interleukin-2 Manufacturing Base, Sales Area and Its Competitors
Table 113. Creative Bioarray Recombinant Human Interleukin-2 Product Portfolios and Specifications
Table 114. Creative Bioarray Recombinant Human Interleukin-2 Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2019-2024)
Table 115. Creative Bioarray Main Business
Table 116. Creative Bioarray Latest Developments
Table 1. Recombinant Human Interleukin-2 Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Recombinant Human Interleukin-2 Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Pharmaceutical Grade
Table 4. Major Players of Other
Table 5. Global Recombinant Human Interleukin-2 Sales by Type (2019-2024) & (kg)
Table 6. Global Recombinant Human Interleukin-2 Sales Market Share by Type (2019-2024)
Table 7. Global Recombinant Human Interleukin-2 Revenue by Type (2019-2024) & ($ million)
Table 8. Global Recombinant Human Interleukin-2 Revenue Market Share by Type (2019-2024)
Table 9. Global Recombinant Human Interleukin-2 Sale Price by Type (2019-2024) & (US$/g)
Table 10. Global Recombinant Human Interleukin-2 Sale by Application (2019-2024) & (kg)
Table 11. Global Recombinant Human Interleukin-2 Sale Market Share by Application (2019-2024)
Table 12. Global Recombinant Human Interleukin-2 Revenue by Application (2019-2024) & ($ million)
Table 13. Global Recombinant Human Interleukin-2 Revenue Market Share by Application (2019-2024)
Table 14. Global Recombinant Human Interleukin-2 Sale Price by Application (2019-2024) & (US$/g)
Table 15. Global Recombinant Human Interleukin-2 Sales by Company (2019-2024) & (kg)
Table 16. Global Recombinant Human Interleukin-2 Sales Market Share by Company (2019-2024)
Table 17. Global Recombinant Human Interleukin-2 Revenue by Company (2019-2024) & ($ millions)
Table 18. Global Recombinant Human Interleukin-2 Revenue Market Share by Company (2019-2024)
Table 19. Global Recombinant Human Interleukin-2 Sale Price by Company (2019-2024) & (US$/g)
Table 20. Key Manufacturers Recombinant Human Interleukin-2 Producing Area Distribution and Sales Area
Table 21. Players Recombinant Human Interleukin-2 Products Offered
Table 22. Recombinant Human Interleukin-2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Recombinant Human Interleukin-2 Sales by Geographic Region (2019-2024) & (kg)
Table 26. Global Recombinant Human Interleukin-2 Sales Market Share Geographic Region (2019-2024)
Table 27. Global Recombinant Human Interleukin-2 Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Recombinant Human Interleukin-2 Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Recombinant Human Interleukin-2 Sales by Country/Region (2019-2024) & (kg)
Table 30. Global Recombinant Human Interleukin-2 Sales Market Share by Country/Region (2019-2024)
Table 31. Global Recombinant Human Interleukin-2 Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Recombinant Human Interleukin-2 Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Recombinant Human Interleukin-2 Sales by Country (2019-2024) & (kg)
Table 34. Americas Recombinant Human Interleukin-2 Sales Market Share by Country (2019-2024)
Table 35. Americas Recombinant Human Interleukin-2 Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas Recombinant Human Interleukin-2 Sales by Type (2019-2024) & (kg)
Table 37. Americas Recombinant Human Interleukin-2 Sales by Application (2019-2024) & (kg)
Table 38. APAC Recombinant Human Interleukin-2 Sales by Region (2019-2024) & (kg)
Table 39. APAC Recombinant Human Interleukin-2 Sales Market Share by Region (2019-2024)
Table 40. APAC Recombinant Human Interleukin-2 Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC Recombinant Human Interleukin-2 Sales by Type (2019-2024) & (kg)
Table 42. APAC Recombinant Human Interleukin-2 Sales by Application (2019-2024) & (kg)
Table 43. Europe Recombinant Human Interleukin-2 Sales by Country (2019-2024) & (kg)
Table 44. Europe Recombinant Human Interleukin-2 Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe Recombinant Human Interleukin-2 Sales by Type (2019-2024) & (kg)
Table 46. Europe Recombinant Human Interleukin-2 Sales by Application (2019-2024) & (kg)
Table 47. Middle East & Africa Recombinant Human Interleukin-2 Sales by Country (2019-2024) & (kg)
Table 48. Middle East & Africa Recombinant Human Interleukin-2 Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa Recombinant Human Interleukin-2 Sales by Type (2019-2024) & (kg)
Table 50. Middle East & Africa Recombinant Human Interleukin-2 Sales by Application (2019-2024) & (kg)
Table 51. Key Market Drivers & Growth Opportunities of Recombinant Human Interleukin-2
Table 52. Key Market Challenges & Risks of Recombinant Human Interleukin-2
Table 53. Key Industry Trends of Recombinant Human Interleukin-2
Table 54. Recombinant Human Interleukin-2 Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Recombinant Human Interleukin-2 Distributors List
Table 57. Recombinant Human Interleukin-2 Customer List
Table 58. Global Recombinant Human Interleukin-2 Sales Forecast by Region (2025-2030) & (kg)
Table 59. Global Recombinant Human Interleukin-2 Revenue Forecast by Region (2025-2030) & ($ millions)
Table 60. Americas Recombinant Human Interleukin-2 Sales Forecast by Country (2025-2030) & (kg)
Table 61. Americas Recombinant Human Interleukin-2 Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 62. APAC Recombinant Human Interleukin-2 Sales Forecast by Region (2025-2030) & (kg)
Table 63. APAC Recombinant Human Interleukin-2 Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 64. Europe Recombinant Human Interleukin-2 Sales Forecast by Country (2025-2030) & (kg)
Table 65. Europe Recombinant Human Interleukin-2 Revenue Forecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa Recombinant Human Interleukin-2 Sales Forecast by Country (2025-2030) & (kg)
Table 67. Middle East & Africa Recombinant Human Interleukin-2 Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. Global Recombinant Human Interleukin-2 Sales Forecast by Type (2025-2030) & (kg)
Table 69. Global Recombinant Human Interleukin-2 Revenue Forecast by Type (2025-2030) & ($ millions)
Table 70. Global Recombinant Human Interleukin-2 Sales Forecast by Application (2025-2030) & (kg)
Table 71. Global Recombinant Human Interleukin-2 Revenue Forecast by Application (2025-2030) & ($ millions)
Table 72. Cytiva Basic Information, Recombinant Human Interleukin-2 Manufacturing Base, Sales Area and Its Competitors
Table 73. Cytiva Recombinant Human Interleukin-2 Product Portfolios and Specifications
Table 74. Cytiva Recombinant Human Interleukin-2 Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2019-2024)
Table 75. Cytiva Main Business
Table 76. Cytiva Latest Developments
Table 77. Bio-Techne Basic Information, Recombinant Human Interleukin-2 Manufacturing Base, Sales Area and Its Competitors
Table 78. Bio-Techne Recombinant Human Interleukin-2 Product Portfolios and Specifications
Table 79. Bio-Techne Recombinant Human Interleukin-2 Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2019-2024)
Table 80. Bio-Techne Main Business
Table 81. Bio-Techne Latest Developments
Table 82. Lonza Basic Information, Recombinant Human Interleukin-2 Manufacturing Base, Sales Area and Its Competitors
Table 83. Lonza Recombinant Human Interleukin-2 Product Portfolios and Specifications
Table 84. Lonza Recombinant Human Interleukin-2 Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2019-2024)
Table 85. Lonza Main Business
Table 86. Lonza Latest Developments
Table 87. Sartorius CellGenix Basic Information, Recombinant Human Interleukin-2 Manufacturing Base, Sales Area and Its Competitors
Table 88. Sartorius CellGenix Recombinant Human Interleukin-2 Product Portfolios and Specifications
Table 89. Sartorius CellGenix Recombinant Human Interleukin-2 Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2019-2024)
Table 90. Sartorius CellGenix Main Business
Table 91. Sartorius CellGenix Latest Developments
Table 92. Thermo Fisher Scientific Basic Information, Recombinant Human Interleukin-2 Manufacturing Base, Sales Area and Its Competitors
Table 93. Thermo Fisher Scientific Recombinant Human Interleukin-2 Product Portfolios and Specifications
Table 94. Thermo Fisher Scientific Recombinant Human Interleukin-2 Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2019-2024)
Table 95. Thermo Fisher Scientific Main Business
Table 96. Thermo Fisher Scientific Latest Developments
Table 97. Miltenyi Biotec Basic Information, Recombinant Human Interleukin-2 Manufacturing Base, Sales Area and Its Competitors
Table 98. Miltenyi Biotec Recombinant Human Interleukin-2 Product Portfolios and Specifications
Table 99. Miltenyi Biotec Recombinant Human Interleukin-2 Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2019-2024)
Table 100. Miltenyi Biotec Main Business
Table 101. Miltenyi Biotec Latest Developments
Table 102. Akron Biotech Basic Information, Recombinant Human Interleukin-2 Manufacturing Base, Sales Area and Its Competitors
Table 103. Akron Biotech Recombinant Human Interleukin-2 Product Portfolios and Specifications
Table 104. Akron Biotech Recombinant Human Interleukin-2 Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2019-2024)
Table 105. Akron Biotech Main Business
Table 106. Akron Biotech Latest Developments
Table 107. Sino Biological Basic Information, Recombinant Human Interleukin-2 Manufacturing Base, Sales Area and Its Competitors
Table 108. Sino Biological Recombinant Human Interleukin-2 Product Portfolios and Specifications
Table 109. Sino Biological Recombinant Human Interleukin-2 Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2019-2024)
Table 110. Sino Biological Main Business
Table 111. Sino Biological Latest Developments
Table 112. Creative Bioarray Basic Information, Recombinant Human Interleukin-2 Manufacturing Base, Sales Area and Its Competitors
Table 113. Creative Bioarray Recombinant Human Interleukin-2 Product Portfolios and Specifications
Table 114. Creative Bioarray Recombinant Human Interleukin-2 Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2019-2024)
Table 115. Creative Bioarray Main Business
Table 116. Creative Bioarray Latest Developments
LIST OF FIGURES
Figure 1. Picture of Recombinant Human Interleukin-2
Figure 2. Recombinant Human Interleukin-2 Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Recombinant Human Interleukin-2 Sales Growth Rate 2019-2030 (kg)
Figure 7. Global Recombinant Human Interleukin-2 Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Recombinant Human Interleukin-2 Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Recombinant Human Interleukin-2 Sales Market Share by Country/Region (2023)
Figure 10. Recombinant Human Interleukin-2 Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Pharmaceutical Grade
Figure 12. Product Picture of Other
Figure 13. Global Recombinant Human Interleukin-2 Sales Market Share by Type in 2023
Figure 14. Global Recombinant Human Interleukin-2 Revenue Market Share by Type (2019-2024)
Figure 15. Recombinant Human Interleukin-2 Consumed in Medical
Figure 16. Global Recombinant Human Interleukin-2 Market: Medical (2019-2024) & (kg)
Figure 17. Recombinant Human Interleukin-2 Consumed in Culture Medium Supplement
Figure 18. Global Recombinant Human Interleukin-2 Market: Culture Medium Supplement (2019-2024) & (kg)
Figure 19. Recombinant Human Interleukin-2 Consumed in Scientific Research
Figure 20. Global Recombinant Human Interleukin-2 Market: Scientific Research (2019-2024) & (kg)
Figure 21. Global Recombinant Human Interleukin-2 Sale Market Share by Application (2023)
Figure 22. Global Recombinant Human Interleukin-2 Revenue Market Share by Application in 2023
Figure 23. Recombinant Human Interleukin-2 Sales by Company in 2023 (kg)
Figure 24. Global Recombinant Human Interleukin-2 Sales Market Share by Company in 2023
Figure 25. Recombinant Human Interleukin-2 Revenue by Company in 2023 ($ millions)
Figure 26. Global Recombinant Human Interleukin-2 Revenue Market Share by Company in 2023
Figure 27. Global Recombinant Human Interleukin-2 Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global Recombinant Human Interleukin-2 Revenue Market Share by Geographic Region in 2023
Figure 29. Americas Recombinant Human Interleukin-2 Sales 2019-2024 (kg)
Figure 30. Americas Recombinant Human Interleukin-2 Revenue 2019-2024 ($ millions)
Figure 31. APAC Recombinant Human Interleukin-2 Sales 2019-2024 (kg)
Figure 32. APAC Recombinant Human Interleukin-2 Revenue 2019-2024 ($ millions)
Figure 33. Europe Recombinant Human Interleukin-2 Sales 2019-2024 (kg)
Figure 34. Europe Recombinant Human Interleukin-2 Revenue 2019-2024 ($ millions)
Figure 35. Middle East & Africa Recombinant Human Interleukin-2 Sales 2019-2024 (kg)
Figure 36. Middle East & Africa Recombinant Human Interleukin-2 Revenue 2019-2024 ($ millions)
Figure 37. Americas Recombinant Human Interleukin-2 Sales Market Share by Country in 2023
Figure 38. Americas Recombinant Human Interleukin-2 Revenue Market Share by Country (2019-2024)
Figure 39. Americas Recombinant Human Interleukin-2 Sales Market Share by Type (2019-2024)
Figure 40. Americas Recombinant Human Interleukin-2 Sales Market Share by Application (2019-2024)
Figure 41. United States Recombinant Human Interleukin-2 Revenue Growth 2019-2024 ($ millions)
Figure 42. Canada Recombinant Human Interleukin-2 Revenue Growth 2019-2024 ($ millions)
Figure 43. Mexico Recombinant Human Interleukin-2 Revenue Growth 2019-2024 ($ millions)
Figure 44. Brazil Recombinant Human Interleukin-2 Revenue Growth 2019-2024 ($ millions)
Figure 45. APAC Recombinant Human Interleukin-2 Sales Market Share by Region in 2023
Figure 46. APAC Recombinant Human Interleukin-2 Revenue Market Share by Region (2019-2024)
Figure 47. APAC Recombinant Human Interleukin-2 Sales Market Share by Type (2019-2024)
Figure 48. APAC Recombinant Human Interleukin-2 Sales Market Share by Application (2019-2024)
Figure 49. China Recombinant Human Interleukin-2 Revenue Growth 2019-2024 ($ millions)
Figure 50. Japan Recombinant Human Interleukin-2 Revenue Growth 2019-2024 ($ millions)
Figure 51. South Korea Recombinant Human Interleukin-2 Revenue Growth 2019-2024 ($ millions)
Figure 52. Southeast Asia Recombinant Human Interleukin-2 Revenue Growth 2019-2024 ($ millions)
Figure 53. India Recombinant Human Interleukin-2 Revenue Growth 2019-2024 ($ millions)
Figure 54. Australia Recombinant Human Interleukin-2 Revenue Growth 2019-2024 ($ millions)
Figure 55. China Taiwan Recombinant Human Interleukin-2 Revenue Growth 2019-2024 ($ millions)
Figure 56. Europe Recombinant Human Interleukin-2 Sales Market Share by Country in 2023
Figure 57. Europe Recombinant Human Interleukin-2 Revenue Market Share by Country (2019-2024)
Figure 58. Europe Recombinant Human Interleukin-2 Sales Market Share by Type (2019-2024)
Figure 59. Europe Recombinant Human Interleukin-2 Sales Market Share by Application (2019-2024)
Figure 60. Germany Recombinant Human Interleukin-2 Revenue Growth 2019-2024 ($ millions)
Figure 61. France Recombinant Human Interleukin-2 Revenue Growth 2019-2024 ($ millions)
Figure 62. UK Recombinant Human Interleukin-2 Revenue Growth 2019-2024 ($ millions)
Figure 63. Italy Recombinant Human Interleukin-2 Revenue Growth 2019-2024 ($ millions)
Figure 64. Russia Recombinant Human Interleukin-2 Revenue Growth 2019-2024 ($ millions)
Figure 65. Middle East & Africa Recombinant Human Interleukin-2 Sales Market Share by Country (2019-2024)
Figure 66. Middle East & Africa Recombinant Human Interleukin-2 Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa Recombinant Human Interleukin-2 Sales Market Share by Application (2019-2024)
Figure 68. Egypt Recombinant Human Interleukin-2 Revenue Growth 2019-2024 ($ millions)
Figure 69. South Africa Recombinant Human Interleukin-2 Revenue Growth 2019-2024 ($ millions)
Figure 70. Israel Recombinant Human Interleukin-2 Revenue Growth 2019-2024 ($ millions)
Figure 71. Turkey Recombinant Human Interleukin-2 Revenue Growth 2019-2024 ($ millions)
Figure 72. GCC Countries Recombinant Human Interleukin-2 Revenue Growth 2019-2024 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Recombinant Human Interleukin-2 in 2023
Figure 74. Manufacturing Process Analysis of Recombinant Human Interleukin-2
Figure 75. Industry Chain Structure of Recombinant Human Interleukin-2
Figure 76. Channels of Distribution
Figure 77. Global Recombinant Human Interleukin-2 Sales Market Forecast by Region (2025-2030)
Figure 78. Global Recombinant Human Interleukin-2 Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global Recombinant Human Interleukin-2 Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global Recombinant Human Interleukin-2 Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global Recombinant Human Interleukin-2 Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global Recombinant Human Interleukin-2 Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Recombinant Human Interleukin-2
Figure 2. Recombinant Human Interleukin-2 Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Recombinant Human Interleukin-2 Sales Growth Rate 2019-2030 (kg)
Figure 7. Global Recombinant Human Interleukin-2 Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Recombinant Human Interleukin-2 Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Recombinant Human Interleukin-2 Sales Market Share by Country/Region (2023)
Figure 10. Recombinant Human Interleukin-2 Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Pharmaceutical Grade
Figure 12. Product Picture of Other
Figure 13. Global Recombinant Human Interleukin-2 Sales Market Share by Type in 2023
Figure 14. Global Recombinant Human Interleukin-2 Revenue Market Share by Type (2019-2024)
Figure 15. Recombinant Human Interleukin-2 Consumed in Medical
Figure 16. Global Recombinant Human Interleukin-2 Market: Medical (2019-2024) & (kg)
Figure 17. Recombinant Human Interleukin-2 Consumed in Culture Medium Supplement
Figure 18. Global Recombinant Human Interleukin-2 Market: Culture Medium Supplement (2019-2024) & (kg)
Figure 19. Recombinant Human Interleukin-2 Consumed in Scientific Research
Figure 20. Global Recombinant Human Interleukin-2 Market: Scientific Research (2019-2024) & (kg)
Figure 21. Global Recombinant Human Interleukin-2 Sale Market Share by Application (2023)
Figure 22. Global Recombinant Human Interleukin-2 Revenue Market Share by Application in 2023
Figure 23. Recombinant Human Interleukin-2 Sales by Company in 2023 (kg)
Figure 24. Global Recombinant Human Interleukin-2 Sales Market Share by Company in 2023
Figure 25. Recombinant Human Interleukin-2 Revenue by Company in 2023 ($ millions)
Figure 26. Global Recombinant Human Interleukin-2 Revenue Market Share by Company in 2023
Figure 27. Global Recombinant Human Interleukin-2 Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global Recombinant Human Interleukin-2 Revenue Market Share by Geographic Region in 2023
Figure 29. Americas Recombinant Human Interleukin-2 Sales 2019-2024 (kg)
Figure 30. Americas Recombinant Human Interleukin-2 Revenue 2019-2024 ($ millions)
Figure 31. APAC Recombinant Human Interleukin-2 Sales 2019-2024 (kg)
Figure 32. APAC Recombinant Human Interleukin-2 Revenue 2019-2024 ($ millions)
Figure 33. Europe Recombinant Human Interleukin-2 Sales 2019-2024 (kg)
Figure 34. Europe Recombinant Human Interleukin-2 Revenue 2019-2024 ($ millions)
Figure 35. Middle East & Africa Recombinant Human Interleukin-2 Sales 2019-2024 (kg)
Figure 36. Middle East & Africa Recombinant Human Interleukin-2 Revenue 2019-2024 ($ millions)
Figure 37. Americas Recombinant Human Interleukin-2 Sales Market Share by Country in 2023
Figure 38. Americas Recombinant Human Interleukin-2 Revenue Market Share by Country (2019-2024)
Figure 39. Americas Recombinant Human Interleukin-2 Sales Market Share by Type (2019-2024)
Figure 40. Americas Recombinant Human Interleukin-2 Sales Market Share by Application (2019-2024)
Figure 41. United States Recombinant Human Interleukin-2 Revenue Growth 2019-2024 ($ millions)
Figure 42. Canada Recombinant Human Interleukin-2 Revenue Growth 2019-2024 ($ millions)
Figure 43. Mexico Recombinant Human Interleukin-2 Revenue Growth 2019-2024 ($ millions)
Figure 44. Brazil Recombinant Human Interleukin-2 Revenue Growth 2019-2024 ($ millions)
Figure 45. APAC Recombinant Human Interleukin-2 Sales Market Share by Region in 2023
Figure 46. APAC Recombinant Human Interleukin-2 Revenue Market Share by Region (2019-2024)
Figure 47. APAC Recombinant Human Interleukin-2 Sales Market Share by Type (2019-2024)
Figure 48. APAC Recombinant Human Interleukin-2 Sales Market Share by Application (2019-2024)
Figure 49. China Recombinant Human Interleukin-2 Revenue Growth 2019-2024 ($ millions)
Figure 50. Japan Recombinant Human Interleukin-2 Revenue Growth 2019-2024 ($ millions)
Figure 51. South Korea Recombinant Human Interleukin-2 Revenue Growth 2019-2024 ($ millions)
Figure 52. Southeast Asia Recombinant Human Interleukin-2 Revenue Growth 2019-2024 ($ millions)
Figure 53. India Recombinant Human Interleukin-2 Revenue Growth 2019-2024 ($ millions)
Figure 54. Australia Recombinant Human Interleukin-2 Revenue Growth 2019-2024 ($ millions)
Figure 55. China Taiwan Recombinant Human Interleukin-2 Revenue Growth 2019-2024 ($ millions)
Figure 56. Europe Recombinant Human Interleukin-2 Sales Market Share by Country in 2023
Figure 57. Europe Recombinant Human Interleukin-2 Revenue Market Share by Country (2019-2024)
Figure 58. Europe Recombinant Human Interleukin-2 Sales Market Share by Type (2019-2024)
Figure 59. Europe Recombinant Human Interleukin-2 Sales Market Share by Application (2019-2024)
Figure 60. Germany Recombinant Human Interleukin-2 Revenue Growth 2019-2024 ($ millions)
Figure 61. France Recombinant Human Interleukin-2 Revenue Growth 2019-2024 ($ millions)
Figure 62. UK Recombinant Human Interleukin-2 Revenue Growth 2019-2024 ($ millions)
Figure 63. Italy Recombinant Human Interleukin-2 Revenue Growth 2019-2024 ($ millions)
Figure 64. Russia Recombinant Human Interleukin-2 Revenue Growth 2019-2024 ($ millions)
Figure 65. Middle East & Africa Recombinant Human Interleukin-2 Sales Market Share by Country (2019-2024)
Figure 66. Middle East & Africa Recombinant Human Interleukin-2 Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa Recombinant Human Interleukin-2 Sales Market Share by Application (2019-2024)
Figure 68. Egypt Recombinant Human Interleukin-2 Revenue Growth 2019-2024 ($ millions)
Figure 69. South Africa Recombinant Human Interleukin-2 Revenue Growth 2019-2024 ($ millions)
Figure 70. Israel Recombinant Human Interleukin-2 Revenue Growth 2019-2024 ($ millions)
Figure 71. Turkey Recombinant Human Interleukin-2 Revenue Growth 2019-2024 ($ millions)
Figure 72. GCC Countries Recombinant Human Interleukin-2 Revenue Growth 2019-2024 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Recombinant Human Interleukin-2 in 2023
Figure 74. Manufacturing Process Analysis of Recombinant Human Interleukin-2
Figure 75. Industry Chain Structure of Recombinant Human Interleukin-2
Figure 76. Channels of Distribution
Figure 77. Global Recombinant Human Interleukin-2 Sales Market Forecast by Region (2025-2030)
Figure 78. Global Recombinant Human Interleukin-2 Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global Recombinant Human Interleukin-2 Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global Recombinant Human Interleukin-2 Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global Recombinant Human Interleukin-2 Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global Recombinant Human Interleukin-2 Revenue Market Share Forecast by Application (2025-2030)
